Daily Digest: Marine brokers and Brexit disruption, Marsh reports Q3 growth, Stocks rebound after Milton – Insurance Day Read more
Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study – Benzinga Read more
EUR/GBP Price Analysis: Mixed outlook as selling pressure rises, 20-day SMA rejects buyers – FXStreet Read more